Developing
Health·1d agoAI summary
UniQure to Seek FDA Approval for Huntington's Disease Gene Therapy
UniQure plans to seek FDA accelerated approval for its Huntington's disease gene therapy, using three-year data from a Phase 1/2 study. This follows a recent FDA meeting that reversed previous criticisms of the evidence, with shares soaring 70%.
C
CNBC US Markets